Date published: 2026-1-31

1-800-457-3801

SCBT Portrait Logo
Seach Input

POLR2G Inhibitors

POLR2G inhibitors belong to a class of compounds that specifically target the POLR2G protein, a key component of the RNA polymerase II complex. RNA polymerase II is an essential enzyme responsible for transcribing DNA into messenger RNA (mRNA) during the process of transcription. POLR2G, one of the subunits of RNA polymerase II, plays a crucial role in the catalytic activity of the enzyme. The inhibitors designed to selectively modulate POLR2G function aim to interfere with the transcription process at its core, influencing gene expression and subsequent protein synthesis.

POLR2G inhibitors involves binding to the POLR2G subunit, disrupting its normal function and impeding the elongation phase of transcription. By inhibiting POLR2G, these compounds can potentially lead to the downregulation of specific genes, offering a tool for researchers to study gene expression patterns and unravel the intricate regulatory networks within cells. The development of POLR2G inhibitors represents a valuable contribution to the field of molecular biology, providing scientists with a means to explore the intricacies of transcriptional control and furthering our understanding of the molecular mechanisms governing gene expression. As researchers continue to investigate the specific effects and applications of POLR2G inhibitors, these compounds hold promise for uncovering new insights into the fundamental processes that govern cellular function and gene regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Binds directly to RNA polymerase II and prevents the elongation phase of RNA transcription.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Binds to XPB, a subunit of TFIIH, leading to the inhibition of RNA polymerase II mediated transcription.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits transcription initiation and elongation by targeting RNA polymerase II.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Inhibits CDK9, a component of P-TEFb, which is necessary for phosphorylating the C-terminal domain of POLR2A.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Termination of RNA chain elongation due to incorporation into RNA and subsequent chain termination.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interacts with DNA and prevents the RNA polymerase from continuing RNA synthesis.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can increase the half-life of proteins, potentially affecting POLR2G turnover.

ICRF-193

21416-68-2sc-200889
sc-200889A
1 mg
5 mg
$341.00
$927.00
7
(1)

Inhibits DNA topoisomerase II, leading to an indirect effect on transcriptional regulation.

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

Inhibits RNA polymerase I, with indirect effects on overall transcriptional regulation.